Eli Lily

N308EL

2020 GULFSTREAM AEROSPACE CORP GVII-G500

Eli Lilly and Company (NYSE: LLY) stands as a global healthcare pioneer, uniting caring with discovery to create medicines that make life better for people around the world. As the most valuable pharmaceutical company by market cap, Lilly is revolutionizing the treatment of diabetes, obesity, and Alzheimer's disease with breakthrough therapies like Mounjaro (tirzepatide), Zepbound, and Kisunla. Building on a century-long legacy as the first company to mass-produce insulin, the Indianapolis-based giant continues to lead the industry in biotech innovation, delivering critical solutions in oncology and immunology. Driven by a robust pipeline and a commitment to patient access, Eli Lilly remains the premier name in cutting-edge medical science and sustainable healthcare growth.